Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHSTX vs. ETHSX: which is better?

Bottom line

PHSTX vs ETHSX: the short answer

PHSTX (Putnam Global Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both mutual funds.

But PHSTX is far broader, holding 115 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

PHSTX is cheaper at 1.04% vs 1.18% — a difference of $14 a year per $10,000 invested.

Over five years, PHSTX returned +6.5% a year vs +5.3% for ETHSX.

Updated Nov 19, 2026

PHSTX vs ETHSX side by side

PHSTXETHSX
TypeMutual fundMutual fund
Fund familyFranklin TempletonMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.04%1.18%
Annual cost per $10k$104$118
10-yr cost on $10k (prospectus)$1,772$1,911
Max front load5.75%5.25%
12b-1 fee0.25%0.25%
1-yr return−4.6%−1.9%
5-yr return (annualized)+6.5%+5.3%
10-yr return (annualized)+6.9%+6.4%
Best quarter+17.5%+14.2%
Worst quarter−12.3%−12.1%
Net assets (fund)$1.5B$757.9M
Number of holdings11542
Portfolio turnover67%3%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPHSTXETHSXDifference
2024+1.3%+3.5%−2.3%
2023+9.0%+5.7%+3.4%
2022−4.7%−9.4%+4.7%
2021+19.4%+22.1%−2.6%
2020+15.9%+13.0%+2.9%
2019+30.2%+26.0%+4.2%
2018−0.6%+6.0%−6.6%
2017+15.3%+16.2%−1.0%
2016−11.7%−14.9%+3.2%
2015+7.5%+8.4%−0.9%

Source: Fund prospectus bar charts

Holdings overlap

16 of PHSTX's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingPHSTXETHSX
Eli Lilly & Co.13.15%12.47%
Johnson & Johnson8.46%6.45%
UnitedHealth Group, Inc.6.93%5.49%
AbbVie, Inc.6.05%6.46%
Novartis AG5.13%1.65%
Merck & Co., Inc.4.88%5.08%
AstraZeneca plc4.67%6.24%
Thermo Fisher Scientific, Inc.4.50%2.79%
Intuitive Surgical, Inc.4.04%2.72%
Sanofi SA3.23%2.95%
Roche Holding AG2.79%5.44%
Gilead Sciences, Inc.2.63%3.34%
Vertex Pharmaceuticals, Inc.1.97%3.38%
Novo Nordisk A/S1.90%1.71%
Boston Scientific Corp.1.80%2.18%

Source: SEC Form N-PORT

PHSTX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between PHSTX and ETHSX?
PHSTX (Putnam Global Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both mutual funds. But PHSTX is far broader, holding 115 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, PHSTX or ETHSX?
PHSTX has the lower expense ratio (1.04%).
Should I own both PHSTX and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.